Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 1999

View Archived Issues

Low-dose clozapine reduces drug-induced psychosis in Parkinson's disease

U.S. patent issues to RCT for novel diabetes vaccine

Generex's buccal insulin effective in short-term clinical trials

Estrogen provides neuroprotective effects in ovariectomized rats

TerraGen acquires Xenova Discovery

Hemophiliac mice effectively treated with a single dose of gene therapy

Sibia Neurosciences licenses TBA technology to Bristol-Myers Squibb

PowderJect presents positive data using PowderJect DNA vaccine

Alteon: Q4 and year-end 1998 highlights

Stanford Rook establishes strategic research collaboration with Genesis

Production and activity of new antimicrobial compound described by Teijin

Inhibitors of MTP from Wakunaga claimed for lipoprotein disorders

Metabolically stable antiadhesion agents in development at Daikin

Dual-action antiasthmatic agents described in patent literature by Kowa

Available for licensing from NIH: cloned genomes of infectious HCV and uses thereof

Novel compounds from Nippon Kayaku promote neuronal differentiation

Progress with AltaRex's AIT products for cancer

MCC-135 improves LV function and prolongs survival in hamster model of cardiomyopathy

Results from SAR studies on Ariflo presented by SmithKline Beecham at ACS meeting

VRT-21493: a representative new HCV NS3 protease inhibitor designed by Vertex

Potent, selective peptidomimetic thrombin inhibitors emerge from U.S.-Canadian partnership

Novel inotropic agents from Prassis-Sigma-Tau compare favorably with digoxin in animal models

Enzon files IND for PEG-camptothecin

E-047/1 more effective than known antiarrhythmics against ventricular fibrillation

FDA decides to continue review of Relenza NDA

First launch for RiboGene's intranasal metoclopramide

EntreMed and NCI sign CRADA for 2-methoxyestradiol

Alkermes discontinues RMP-7/carboplatin brain tumor trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...